Medtide Inc. filed its Monthly Return for Equity Issuer for March 2026, detailing a major capital restructuring that brings all outstanding shares onto The Stock Exchange of Hong Kong (HKEX).
Key developments • Share conversion: On 9 March 2026, 68.20 million previously unlisted ordinary shares were converted into the same number of H shares. • Expanded share base: Total issued share capital rose from 73.60 million to 141.80 million H shares, each with a par value of RMB 1.00. The unlisted share class was eliminated. • Authorised/issued capital: Correspondingly increased to RMB 141.80 million from RMB 73.60 million. • Public-float compliance: The company confirmed that post-conversion it satisfies the HKEX minimum public-float threshold of 25 % for the H-share class. • No other instruments: The filing shows no outstanding share options, warrants, convertible securities or treasury-share movements during the month.
Administrative details The return was submitted on 8 April 2026 by Joint Company Secretary Ng Tung Ching Raphael, affirming that all regulatory and listing-rule requirements related to the share conversion were met.
Comments